321 Phase I clinical trial assessing the combination of systemic chemokine modulatory regimen targeting TLR3 with neoadjuvant chemotherapy in triple negative breast cancer

• Cayla Ford,
• Victoria Fitzpatrick,
• Per Basse,
• Marie Quinn,
• Agnieszka Witkiewicz

Affiliations

Cayla Ford

1Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Victoria Fitzpatrick

1Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Per Basse

1Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Marie Quinn

1Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Agnieszka Witkiewicz

1Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA